Ranbaxy Laboratories trades in green on the BSE

21 Feb 2012 Evaluate

Ranbaxy Laboratories is currently trading at Rs. 452.00, up by 3.95 points or 0.88% from its previous closing of Rs. 448.05 on the BSE.

The scrip opened at Rs. 451.95 and has touched a high and low of Rs. 454.20 and Rs. 445.15 respectively. So far 52152 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 570.00 on 02-Aug-2011 and a 52 week low of Rs. 366.50 on 19-Dec-2011.

Last one week high and low of the scrip stood at Rs. 459.10 and Rs. 433.00 respectively. The current market cap of the company is Rs. 19033.63 crore.

The promoters holding in the company stood at 63.68% while Institutions and Non-Institutions held 19.96% and 14.60% respectively.

Ranbaxy Laboratories’ subsidiary-Ranbaxy Australia Pty (RAPL)- has launched Atorvastatin 10mg, 20mg, 40mg and 80mg tablets in the Australian market, after receiving approval from the Therapeutic Goods Administration (TGA), the regulatory authority in Australia.

The company has introduced the product under the brand name ‘Trovas’ and the drug will be available in bottles and blister packs, through retail pharmacy chains. Atorvastatin, a cholesterol reducing drug, is the most prescribed statin in Australia and represents the largest patent expiry opportunity ever, in the Australian pharmaceuticals market.

Ranbaxy Laboratories is India's largest pharmaceutical company. The company has global presence in 49 countries and is ranked amongst top ten global generics companies. Ranbaxy has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam.

Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 920.90
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×